Literature DB >> 12566018

Use of glaucoma drainage devices in the management of glaucoma associated with aniridia.

Claudia P Arroyave1, Ingrid U Scott, Steven J Gedde, Richard K Parrish, William J Feuer.   

Abstract

PURPOSE: To describe intraocular pressure (IOP) and visual acuity outcomes after glaucoma drainage device placement in eyes with glaucoma associated with aniridia.
DESIGN: Retrospective, noncomparative, consecutive, interventional case series.
METHODS: The medical records of all patients who underwent glaucoma drainage device placement for the management of glaucoma associated with aniridia at the Bascom Palmer Eye Institute between January 1, 1989, and December 31, 1999, were reviewed.
RESULTS: The study included eight eyes of five patients with a median age at the time of glaucoma drainage device placement of 92 months (range, 10- 495 months) and a median follow-up of 19 months (range, 11- 33 months). Preoperatively, the mean IOP was 35 mm Hg using a mean of one antiglaucoma medication. Postoperatively, the mean IOP was reduced to 14.9 mm Hg and no patient was using antiglaucoma medication. Final visual acuity was improved compared with preoperatively in five of eight eyes (63%) and remained unchanged in two eyes (25%). Loss of light perception occurred in one eye owing to retinal detachment. Success rates using Kaplan-Meier survival analysis were 100% at 6 months and 88% at 1 year.
CONCLUSIONS: Glaucoma drainage device placement for glaucoma associated with aniridia achieves IOP control and vision preservation in most patients.

Entities:  

Mesh:

Year:  2003        PMID: 12566018     DOI: 10.1016/s0002-9394(02)01934-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Aqueous shunts for glaucoma.

Authors:  D S Minckler; S S Vedula; T J Li; M C Mathew; R S Ayyala; B A Francis
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma.

Authors:  Radwan Almousa; Damian B Lake
Journal:  Int Ophthalmol       Date:  2013-10-18       Impact factor: 2.031

3.  Analysis of long-term outcomes for combined pars plana vitrectomy (PPV) and glaucoma tube shunt surgery in eyes with advanced glaucoma.

Authors:  A Gandhi; D M Miller; J M Zink; A K Khatana; C D Riemann; M R Petersen; R E Foster; R A Sisk
Journal:  Eye (Lond)       Date:  2013-12-13       Impact factor: 3.775

4.  [Stage-related therapy of congenital aniridia].

Authors:  B Seitz; B Käsmann-Kellner; A Viestenz
Journal:  Ophthalmologe       Date:  2014-12       Impact factor: 1.059

5.  Clinical outcomes and visual prognostic factors in congenital aniridia.

Authors:  Adam Jacobson; Shahzad I Mian; Brenda L Bohnsack
Journal:  BMC Ophthalmol       Date:  2022-05-25       Impact factor: 2.086

Review 6.  Congenital Aniridia: Clinic, Genetics, Therapeutics, and Prognosis.

Authors:  Pedro Calvão-Pires; R Santos-Silva; F Falcão-Reis; A Rocha-Sousa
Journal:  Int Sch Res Notices       Date:  2014-10-29

7.  Novel use of fibrin sealant for scleral suture free placement of a glaucoma drainage device in advanced scleral thinning.

Authors:  Justin D Harvey; Ronald L Gross; Brian D McMillan
Journal:  Am J Ophthalmol Case Rep       Date:  2017-10-23

Review 8.  Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review

Authors:  Gülizar Soyugelen Demirok; Ümit Ekşioğlu; Mehmet Yakın; Ahmet Kaderli; Sema Tamer Kaderli; Firdevs Örnek
Journal:  Turk J Ophthalmol       Date:  2019-09-03

9.  Use of the XEN gel implant in a patient with aniridia-associated glaucoma.

Authors:  Are Lindland; John-Thomas Edward Michelet; Jon Erik Slagsvold
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-31

10.  Bilateral Deep Sclerectomy with Microperforations as a Successful Secondary Procedure in Aniridia-Associated Glaucoma.

Authors:  Abdulrahman AlDarrab; Rizwan Malik
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.